EFFECT OF NOISE AND MODEL COMPLEXITY ON DETECTION OF AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSON'S DISEASE USING PITCH AND MFCC

被引:2
|
作者
Bhattacharjee, Tanuka [1 ]
Mallela, Jhansi [1 ]
Belur, Yamini [3 ]
Atchayarcmf, Nalini [4 ]
Yadav, Ravi [4 ]
Reddy, Pradeep [4 ]
Gope, Dipanjan [2 ]
Ghosh, Prasanta Kumar [1 ]
机构
[1] Indian Inst Sci, EE Dept, Bengaluru 560012, India
[2] Indian Inst Sci, ECE Dept, Bengaluru 560012, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Speech Pathol & Audiol, Bengaluru 560029, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru 560029, India
关键词
Amyotrophic Lateral Sclerosis; Parkinson's disease; Pitch; Mel-frequency cepstral coefficients; Model complexity; Noise; DYSARTHRIA; SPEECH; ALS;
D O I
10.1109/ICASSP39728.2021.9413997
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Dysarthria due to Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease (PD) impacts both articulation and prosody in an individual's speech. Complex deep neural networks exploit these cues for detection of ALS and PD. These are typically done using recordings in laboratory condition. This study aims to examine the robustness of these cues against background noise and model complexity, which has not been investigated before. We perform classification experiments with pitch and Mel-frequency cepstral coefficients (MFCC) using models of three different complexities and additive white Gaussian noise in four signal-to-noise-ratio (SNR) conditions. The findings are as follows: 1) In clean condition, pitch performs similar to MFCC across most model complexities considered, suggesting that one-dimensional pitch pattern provides discriminative cues for the classification to an extent equal to that of multi-dimensional MFCC, 2) Similar trend is observed in noisy cases when classifiers are trained and tested in matched noise and SNR conditions, 3) When the classifiers trained on clean data are applied in noisy cases, pitch based average classification accuracies are found to be 20.09% and 24.73% higher than those using MFCC for ALS vs. healthy and PD vs. healthy, respectively, suggesting robustness of pitch based classifier against noise and model complexity.
引用
收藏
页码:7313 / 7317
页数:5
相关论文
共 50 条
  • [31] Iron as a therapeutic target for neurodegenerative diseases (Parkinson's disease and amyotrophic lateral sclerosis)
    Devos, D.
    Moreau, C.
    FEBS OPEN BIO, 2018, 8 : 33 - 33
  • [32] Genetic and clinical overlap between Amyotrophic Lateral Sclerosis and Parkinson's disease Introduction
    Regalbuto, S.
    Palmieri, I.
    Gagliardi, S.
    Pansarasa, O.
    Traviglia, G.
    Diamanti, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 280 - 280
  • [33] Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients
    Baade, P. D.
    Fritschi, L.
    Freedman, D. M.
    NEUROEPIDEMIOLOGY, 2007, 28 (01) : 16 - 20
  • [34] Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis
    Yu, L.
    He, X.
    Zhang, L.
    Liu, Z.
    Xu, Y.
    MOVEMENT DISORDERS, 2013, 28 : S398 - S398
  • [35] Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis
    Wallings, Rebecca L.
    Humble, Stewart W.
    Ward, Michael E.
    Wade-Martins, Richard
    TRENDS IN NEUROSCIENCES, 2019, 42 (12) : 899 - 912
  • [36] Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease
    Cui, Can
    Sun, Jiangwei
    Pawitan, Yudi
    Piehl, Fredrik
    Chen, Honglei
    Ingre, Caroline
    Wirdefeldt, Karin
    Evans, Marie
    Andersson, John
    Carrero, Juan-Jesus
    Fang, Fang
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [37] Gene transfer for neuroprotection in animal models of Parkinson's disease and amyotrophic lateral sclerosis
    Bohn, MC
    Connor, B
    Kozlowski, DA
    Mohajeri, MH
    NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS, 2000, 231 : 70 - 89
  • [38] Association Studies of MMP-9 in Parkinson's Disease and Amyotrophic Lateral Sclerosis
    He, Xianghua
    Zhang, Lifang
    Yao, Xiaoli
    Hu, Jing
    Yu, Lihua
    Jia, Hua
    An, Ran
    Liu, Zhuolin
    Xu, Yanming
    PLOS ONE, 2013, 8 (09):
  • [39] Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis
    Devos, David
    Cabantchik, Z. Ioav
    Moreau, Caroline
    Danel, Veronique
    Mahoney-Sanchez, Laura
    Bouchaoui, Hind
    Gouel, Flore
    Rolland, Anne-Sophie
    Duce, James A.
    Devedjian, Jean-Christophe
    Cassereau, Julien
    Bost, Marie
    Abrial, Charlotte
    Muller, Jeanne
    Olivier, Audrey
    Le Masson, Gwendal
    Mathis, Stephane
    Djigo, Dieynaba
    Bonabaud, Sarah
    Deloire, Mathilde
    Genestet, Steeve
    Menanteau, Elsa
    Bourgeois, Pauline
    Lefilliatre, Mathilde
    Viader, Fausto
    Abrou, Mouloud
    Chavanne, Damien
    Bari, Rachida
    Guy, Nathalie
    Arondo, Sophia Sickout
    Rouvet, Sandrine
    Beauvais, Katell
    Aidan, Mathilde
    Madec, Olivier
    Danel-Brunaud, Veronique
    Tard, Celine
    Pleuvret, Marie
    Santraine, Valerie
    Moutarde, Julie
    Couratier, Philippe
    Lautrette, Geraldine
    Machat, Selma
    Penoty, Marie
    Villeneuve, Olivier
    Labetoulle, Clemence
    Catteau, Julie
    Bernard, Emilien
    Svahn, Juliette
    Neuillet, Camille
    Attarian, Shahram
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (02) : 189 - 203
  • [40] Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients
    Salauze, L
    Van der Velden, C
    Lagroye, I
    Veyret, B
    Geffard, M
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2005, 6 (04): : 226 - 233